Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CETP | P11597 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18532443 | 1.00 | LMNA (0.35) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3672161 | 0.96 | LMNA (0.33) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3672162 | 0.96 | LMNA (0.33) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| SCHEMBL3970934 | 0.92 | LMNA (0.44) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| SCHEMBL4076760 | 0.92 | LMNA (0.44) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| SCHEMBL4290542 | 0.92 | LMNA (0.44) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| SCHEMBL4284663 | 0.92 | LMNA (0.44) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3675135 | 0.88 | LMNA (0.41) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3670637 | 0.88 | LMNA (0.41) | LMNAL3MBTL1CETPTDP1ALDH1A1 | |
| SCHEMBL14624506 | 0.87 | LMNA (0.59) | LMNAL3MBTL1TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964224-B1 | POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT | POLYACTIVA PTY LTD (AU) | 2024-07-03 | — | — | EP | disclosed |
| US-20110046982-A1 | METHODS AND COMPOSITIONS RELATED TO VIRAL INHIBITION | CLEMSON UNIVERSITY RESEARCH FOUNDATION (CURF) (US) | 2011-02-24 | — | — | US | disclosed |
| EP-1046649-B1 | Solid phase nucleic acid labeling by transamination | ABBOTT MOLECULAR INC (US) | 2006-06-28 | — | — | EP | disclosed |
| US-6569626-B2 | Hybridization; binding Dna segments; labeling; detection fluorescence | VYSIS, INC. | 2003-05-27 | — | — | US | disclosed |
| US-20020025523-A1 | Probe compositions for chromosome identification and methods | BITTNER MICHAEL L (US) | 2002-02-28 | — | — | US | disclosed |
| US-6277569-B1 | STAINING MIXED DNA SEGMENTS FOR DETECTION OF AT LEAST THREE PRESELECTED TARGET CHROMOSOMES OR REGIONS BY IN SITU HYBRIDIZATION USING MULTIPLE PROBES | VYSIS, INC. | 2001-08-21 | — | — | US | disclosed |
| US-6194563-B1 | TRANSAMINATING THE CYTIDINE BASE OF SOLID-SUPPORT-IMMOBILIZED NUCLEIC ACID WITH A REACTIVE GROUP TO FORM A COVALENT LINKAGE, THEN LINKING A DETECTABLE LABEL TO REACTIVE GROUP; FLUORESCENT HYBRIDIZATION PROBES | VYSIS, INC. | 2001-02-27 | — | — | US | disclosed |
| EP-1046649-A1 | Solid phase nucleic acid labeling by transamination | VYSIS, Inc. (US) | 2000-10-25 | — | — | EP | disclosed |
| EP-0558732-B1 | PRODUCTION OF CHROMOSOME REGION SPECIFIC DNA SEQUENCES AND TRANSAMINATION | AMOCO CORP (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0558740-B1 | PROBE COMPOSITION FOR GENOME IDENTIFICATION AND METHODS | VYSIS INC (US) | 1998-08-05 | — | — | EP | disclosed |
| US-5789161-A | Methods for genome identification using direct label probe composition | AMOCO CORPORATION (US) | 1998-08-04 | — | — | US | disclosed |
| US-5776688-A | Methods for detection by in situ hybridization of multiple chromosomes or regions thereof | VYSIS, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5663319-A | Probe compositions for chromosome identification and methods | VYSIS, INC. (US) | 1997-09-02 | — | — | US | disclosed |
| EP-0787805-A2 | Probe compositions for chromosome identification and method | AMOCO CORPORATION (US) | 1997-08-06 | — | — | EP | disclosed |
| EP-0549709-B1 | PROBE COMPOSITIONS FOR CHROMOSOME IDENTIFICATION AND METHODS | AMOCO CORP (US) | 1997-01-29 | — | — | EP | disclosed |
| US-5506350-A | IN PRESENCE OF A TRIFLUOROACETATE CHAOTROPE | BITTNER MICHAEL L (US) | 1996-04-09 | — | — | US | disclosed |
| US-5491224-A | FOR IN SITU HYBRIDIZATION ENUMERATIONS OF SPECIFIC CHROMOSOME CENTROMERES | VYSIS, INC. | 1996-02-13 | — | — | US | disclosed |
| EP-0558740-A1 | PROBE COMPOSITION FOR GENOME IDENTIFICATION AND METHODS | VYSIS, Inc. (US) | 1993-09-08 | — | — | EP | disclosed |
| WO-1993006245-A1 | PROBE COMPOSITION FOR GENOME IDENTIFICATION AND METHODS | AMOCO CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020025523-A1 | Probe compositions for chromosome identification and methods | INCENP, BOD1L1, SMC2 | LMNA 29/4885L3MBTL1 702/4885CETP 3125/4885 |
| US-20110046982-A1 | METHODS AND COMPOSITIONS RELATED TO VIRAL INHIBITION | EIF2AK2, NSUN2, NSUN3 | LMNA 633/4885L3MBTL1 1148/4885CETP 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.